22Apr
Lessons learned after trimming through the fluff of Colombian cannabis
After medical cannabis legalization was approved by Colombian Congress in 2017, we all poured our hopes into promises of a...
20Apr
Medical cannabis cuts prescription drug use by 85%, German patient survey finds
A survey of over 3,500 patients reported an average 85 per cent reduction in the use of other prescription medicines...
17Apr
Cannabis Europa returns to London with patient issues on the agenda
More than 70 international speakers and over 1000 delegates set to attend The Barbican for debates, talks and discussions that...
17Apr
Welsh Liberal Democrats pass motion to protect medical cannabis patients
The motion calls for an end to discrimination faced by people who use CBPMs and is the first time a...
14Apr
True Terpenes: Focusing on Aroma
Over the past decade, $50 billion worth of cannabis products have been made with True Terpenes flavors and formulations, giving...
14Apr
True Terpenes: Focusing on Aroma
Over the past decade, $50 billion worth of cannabis products have been made with True Terpenes flavors and formulations, giving...
11Apr
The Dutch legal cannabis experiment one year on
For decades, the Netherlands embraced a strange compromise: selling and consuming cannabis was tolerated, growing it was criminal. One year...
10Apr
Nominations open for Marijuana Venture’s 40 under 40
Marijuana Venture is now accepting nominations for its 11th annual 40 under 40. The special feature has highlighted more than...
10Apr
Nominations open for Marijuana Venture’s 40 under 40
Marijuana Venture is now accepting nominations for its 11th annual 40 under 40. The special feature has highlighted more than...
07Apr
Your Facility Is Either Making You Money or Costing You Money. Which One Is It?
Michael Gillespie has spent a decade at the intersection of heavy-industrial engineering and cannabis cultivation, first as a consultant, then...
